Canopy Growth 4Q Loss Narrows, Revenue Rises

Dow Jones
06/15
 

By Adriano Marchese

 

Canopy Growth said its fourth-quarter loss narrowed as the company's Canadian cannabis business drove revenue growth and that it expects momentum to continue in the new fiscal year.

For the three months ended March 31, the Smiths Falls, Ontario cannabis company on Monday posted a narrowed net loss of 154.7 million Canadian dollars ($110.6 million), or C$0.40 a share, compared with a loss of C$196 million, or C$1.27 a share, in the comparable quarter a year ago.

Consolidated net revenue rose 10% to C$71.2 million, missing forecasts calling for growth to C$74.3 million.

The company's cannabis revenue rose 20% in the quarter to C$54.5 million, with Canadian medical cannabis sales rising 27% and adult-use cannabis increasing by 1%.

Meanwhile, the company's vaporizer manufacturing business, Storz & Bickel, saw revenue fall 14% to C$16.8 million.

Canopy Growth said that it expects net revenue to grow in fiscal 2027 as improved cultivation practices lift gross margins while cost-cutting measures reduce operating expenses.

The company also expects to achieve positive adjusted earnings before interest, taxes, depreciation and amortization in the year, with gains weighted toward the second half of the year.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

June 15, 2026 07:37 ET (11:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10